<DOC>
	<DOCNO>NCT00069121</DOCNO>
	<brief_summary>This 2 arm study compare efficacy safety intermittent oral Xeloda plus Eloxatin ( oxaliplatin ) fluorouracil/leucovorin patient surgery colon cancer previous chemotherapy . Patients randomize receive either 1 ) XELOX ( Xeloda 1000mg/m2 po bid day 1-15 + oxaliplatin ) 3 week cycle 2 ) 5-fluorouracil + leucovorin 4 8 week cycle . The anticipated time study treatment disease progression target sample size 500+ individual .</brief_summary>
	<brief_title>A Study Xeloda ( Capecitabine ) Plus Oxaliplatin Patients With Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>adult patient &gt; =18 year age ; colon cancer ; complete tumor resection . prior treatment cytotoxic chemotherapy , radiotherapy , immunotherapy currently treat colon cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>